Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
1010396-92-2
|
| gptkbp:drugClass |
GABAA receptor positive allosteric modulator
|
| gptkbp:hasInChIKey |
QZKQKQKQKQKQKQ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C17H12Cl2N2O2
|
| gptkbp:hasReportedEffect |
anxiolytic effects in animal studies
|
| gptkbp:hasResearchUse |
investigational drug
|
| gptkbp:hasSMILES |
C1=CC(=C(C=C1Cl)Cl)C2=CC=C(O2)C(=O)NCC3=CN=CC=C3
|
| https://www.w3.org/2000/01/rdf-schema#label |
CLC-23
|
| gptkbp:IUPACName |
5-(2,4-dichlorophenyl)-N-(pyridin-3-ylmethyl)furan-2-carboxamide
|
| gptkbp:PubChem_CID |
CHEMBL2103887
25185398 |
| gptkbp:synonym |
5-(2,4-dichlorophenyl)-N-(3-pyridinylmethyl)-2-furancarboxamide
|
| gptkbp:bfsParent |
gptkb:Combat_Logistics_Company_23
|
| gptkbp:bfsLayer |
7
|